Overview Message from CEO Ligand Leadership Board of Directors Scientific Advisors

Overview Pre-Clinical Phase I Phase II Phase III NDA/Marketed Full Pipeline

R&D Programs Intracellular Technology HepDirect Technology

Overview Collaborations Royalties

Overview Opportunities Contact Business Development

Overview News Presentations & Events Analyst Coverage Stock Information SEC Documents Corporate Governance Email Alerts